Getting compounded semaglutide requires a prescription from a licensed healthcare provider, filled through a compounding pharmacy. The process typically involves a medical evaluation (often through telehealth), a prescription written specifically for a compounded version, and a pharmacy that prepares the medication to order. However, the regulatory landscape shifted significantly in early 2025, and understanding what’s currently legal matters before you start.
The FDA Shortage Is Over, and That Changes Everything
For much of 2023 and 2024, semaglutide was on the FDA’s official drug shortage list. That designation opened a legal window: compounding pharmacies could legally produce copies of brand-name semaglutide products like Ozempic and Wegovy. With the shortage resolved as of February 2025, that window has largely closed.
Federal law generally prohibits compounding pharmacies from making copies of commercially available, FDA-approved drugs. The FDA announced a short enforcement grace period after resolving the shortage, giving standard compounding pharmacies until April 22, 2025, and registered outsourcing facilities until May 22, 2025, to wind down their semaglutide operations. After those dates, the FDA signaled it would begin enforcing restrictions on compounded semaglutide that copies the approved products.
This doesn’t necessarily mean all compounded semaglutide has vanished. Some pharmacies may still compound it under narrow legal circumstances, such as making meaningful modifications to the formulation (different dosage forms, for example) rather than producing direct copies. But the broad, easy access to compounded semaglutide that existed during the shortage is no longer guaranteed, and availability varies depending on when you’re reading this and how enforcement plays out.
What You Need to Get a Prescription
Compounded semaglutide is a prescription medication, full stop. Any provider or website offering it without a medical evaluation is operating outside the law. The evaluation process looks similar to what you’d go through for brand-name semaglutide:
- Weight and BMI criteria: Semaglutide for weight management is prescribed alongside diet and exercise for patients who have at least one weight-related medical condition, such as high blood pressure, type 2 diabetes, or high cholesterol.
- Medical history review: Your provider will screen for conditions that make semaglutide unsafe. These include type 1 diabetes, severe gastroparesis (a condition where your stomach can’t empty food normally), a personal or family history of a rare thyroid cancer called medullary thyroid carcinoma, and a history of pancreatitis. Kidney disease, diabetic eye complications, and digestive problems also require careful consideration.
- Pregnancy: Semaglutide should not be used during pregnancy, and you need to stop it at least two months before planning to conceive.
- Ongoing monitoring: Expect regular follow-up visits. Your provider will likely order blood and urine tests periodically to check for side effects and make sure the medication is working as intended.
Many people access compounded semaglutide through telehealth platforms that connect you with a prescribing provider and a partnered compounding pharmacy. This is a legitimate route, but the quality of these platforms varies enormously.
Two Types of Compounding Pharmacies
Not all compounding pharmacies operate under the same rules, and the distinction matters for your safety. Federal law creates two categories.
Section 503A pharmacies are traditional compounding pharmacies, typically staffed by a licensed pharmacist who prepares medications based on individual prescriptions. These pharmacies are exempt from the FDA’s current good manufacturing practice (CGMP) requirements, which means they face less rigorous production standards. They’re primarily regulated by their state pharmacy board, and most are limited to filling prescriptions for patients within their own state. Pharmacies in states that haven’t signed a specific oversight agreement with the FDA can ship no more than 5 percent of their compounded products across state lines.
Section 503B outsourcing facilities are registered with the FDA and subject to routine FDA inspections on a risk-based schedule. They must follow the same CGMP requirements that apply to conventional drug manufacturers, including batch testing and quality controls. They can prepare larger quantities and ship more broadly. The FDA explicitly encourages patients who need compounded drugs to obtain them from 503B outsourcing facilities when possible, because of this higher oversight standard.
If you’re choosing between the two, a 503B outsourcing facility offers more built-in safety checks. You can verify a facility’s registration on the FDA’s website.
How to Vet a Provider or Pharmacy
The surge in semaglutide demand created a parallel surge in questionable sellers. Here’s what to look for and what to avoid.
Legitimate telehealth platforms that prescribe compounded semaglutide will require a real medical consultation before writing a prescription. They’ll ask about your health history, current medications, and contraindications. Many credible platforms carry LegitScript Healthcare Certification, a third-party verification trusted by Google, Meta, Microsoft, Visa, and Mastercard. Certified businesses must demonstrate proper licensure in every state they serve, comply with prescription validity laws, protect patient privacy, and advertise transparently. Look for the certification seal on the website.
Red flags that should make you close the tab:
- No prescription required: Any site selling semaglutide without a medical evaluation is illegal.
- Vague sourcing: The pharmacy should be able to tell you whether it’s a 503A or 503B facility and where it sources its ingredients.
- Prices that seem impossibly low: Compounding still costs money. Dramatically cheap options may indicate counterfeit or substandard products.
- No listed pharmacist or medical director: Legitimate operations have identifiable, licensed professionals behind them.
- Packaging that looks off: The FDA advises checking whether the drug or packaging looks different from what you’d normally expect.
Counterfeit semaglutide is a real and documented problem. Fake products may contain no semaglutide at all, the wrong ingredients, or incorrect amounts. In one confirmed case, a counterfeit semaglutide pen actually contained insulin, which could cause dangerously low blood sugar in someone who doesn’t need it.
The Salt Form Problem
One safety concern that most patients don’t hear about involves the chemical form of semaglutide used by compounding pharmacies. The FDA-approved products (Ozempic and Wegovy) use semaglutide in its base form. Many compounding pharmacies have instead used salt forms of semaglutide, such as semaglutide sodium or semaglutide acetate. These are chemically distinct substances.
This isn’t a minor technicality. Changing the salt form of a peptide drug can alter how it dissolves, how stable it remains in solution, and how your body absorbs and processes it. The FDA has stated it is unaware of any scientific basis for compounding with these salt forms and has effectively categorized them as unapproved drug substances. The agency has issued warning letters to telehealth companies making claims that salt-form compounded semaglutide is equivalent to the brand-name products.
If you’re considering compounded semaglutide, ask the pharmacy directly whether they use semaglutide base or a salt form. A pharmacy that uses the base form and can provide third-party testing results for potency and sterility is a stronger choice.
What the Process Typically Looks Like
For most people, the practical steps follow this sequence. You start with a telehealth visit or an in-person appointment with a provider who prescribes weight management medications. If you meet the clinical criteria, the provider writes a prescription specifying compounded semaglutide, including the dose and concentration. That prescription goes to a compounding pharmacy, either one you’ve chosen or one the telehealth platform partners with. The pharmacy prepares your medication (usually as a subcutaneous injection in a vial, though some offer other forms) and ships it to you, typically with syringes, alcohol swabs, and injection instructions.
You’ll generally start at a low dose and increase gradually over several weeks to minimize gastrointestinal side effects like nausea. Follow-up appointments, usually monthly or every few months, allow your provider to adjust dosing and monitor for any problems. The whole cycle from initial consultation to receiving your first shipment often takes one to two weeks, though some platforms advertise faster turnaround.
Cost Without Insurance
One of the main reasons people seek compounded semaglutide is cost. Brand-name Wegovy and Ozempic carry list prices exceeding $1,000 per month, and insurance coverage remains inconsistent, especially for weight management. Compounded versions have historically cost between $150 and $500 per month depending on the dose, pharmacy, and whether a telehealth consultation fee is bundled in.
Keep in mind that compounded medications are almost never covered by insurance. You’re paying out of pocket for the medication, the provider visit, and often shipping. Some platforms offer subscription models with monthly charges that include the consultation, medication, and supplies. Compare total costs rather than just the advertised medication price, since consultation fees, shipping, and supply costs can add up.